Aelis Farma S.A.

AELIS.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Market Cap€13,365€27,410€165,297€173,014
- Cash€10,791€14,051€12,585€20,230
+ Debt€6,890€6,080€5,084€4,038
Enterprise Value€9,464€19,439€157,796€156,822
Revenue€895€1,438€4,124€5,320
% Growth-37.8%-65.1%-22.5%
Gross Profit€895€1,438€4,124€6,657
% Margin100%100%100%125.1%
EBITDA-€4,104-€4,458-€3,538-€3,964
% Margin-458.5%-310%-85.8%-74.5%
Net Income-€4,323-€3,873-€3,583-€3,445
% Margin-483%-269.3%-86.9%-64.8%
EPS Diluted-0.32-0.28-0.27-0.26
% Growth-14.3%-3.7%-3.8%
Operating Cash Flow-€3,883-€3,471-€8,177-€4,918
Capital Expenditures-€6-€25-€165-€6
Free Cash Flow-€3,883-€3,496-€8,342-€4,924
Aelis Farma S.A. (AELIS.PA) Financial Statements & Key Stats | AlphaPilot